Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 37.31B | 38.18B | 33.10B | 30.50B | 28.45B | 26.72B |
Gross Profit | 6.91B | 6.96B | 6.47B | 5.87B | 5.73B | 5.46B |
EBITDA | 2.53B | 2.97B | 2.39B | 2.22B | 2.33B | 2.03B |
Net Income | 1.28B | 1.27B | 930.89M | 883.50M | 975.88M | 788.39M |
Balance Sheet | ||||||
Total Assets | 19.09B | 19.34B | 19.83B | 15.62B | 15.25B | 14.72B |
Cash, Cash Equivalents and Short-Term Investments | 799.00M | 1.16B | 840.81M | 758.87M | 776.21M | 962.08M |
Total Debt | 2.46B | 1.43B | 3.31B | 1.50B | 2.30B | 2.68B |
Total Liabilities | 8.73B | 8.58B | 10.31B | 7.05B | 7.54B | 7.95B |
Stockholders Equity | 10.03B | 10.42B | 9.21B | 8.28B | 7.45B | 6.55B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.21B | -1.59B | 876.16M | 322.79M | 1.25B |
Operating Cash Flow | 0.00 | 5.66B | 1.14B | 3.19B | 1.78B | 2.51B |
Investing Cash Flow | 0.00 | -3.34B | -2.75B | -2.27B | -1.49B | -1.26B |
Financing Cash Flow | 0.00 | -2.00B | 1.70B | -923.10M | -500.68M | -1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥8.93B | 11.35 | 2.88% | 11.34% | 22.75% | ||
68 Neutral | ¥5.82B | 11.25 | 2.64% | 12.55% | ― | ||
66 Neutral | ¥8.44B | 6.62 | 1.74% | 15.34% | ― | ||
64 Neutral | ¥4.74B | 5.14 | 4.38% | 10.95% | -24.17% | ||
63 Neutral | $16.85B | 11.25 | -7.01% | 2.93% | 1.72% | -24.85% | |
50 Neutral | ¥2.79B | 139.38 | 1.48% | 5.04% | -356.40% |